199 related articles for article (PubMed ID: 25849892)
1. Diverse effects of LPA4, LPA5 and LPA6 on the activation of tumor progression in pancreatic cancer cells.
Ishii S; Hirane M; Fukushima K; Tomimatsu A; Fukushima N; Tsujiuchi T
Biochem Biophys Res Commun; 2015 May; 461(1):59-64. PubMed ID: 25849892
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidic acid (LPA) signaling via LPA
Takahashi K; Fukushima K; Onishi Y; Inui K; Node Y; Fukushima N; Honoki K; Tsujiuchi T
Biochem Biophys Res Commun; 2017 Jan; 483(1):652-657. PubMed ID: 27993681
[TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidic acid signaling via LPA
Fukushima K; Takahashi K; Yamasaki E; Onishi Y; Fukushima N; Honoki K; Tsujiuchi T
Exp Cell Res; 2017 Mar; 352(1):139-145. PubMed ID: 28189636
[TBL] [Abstract][Full Text] [Related]
4. Promotion of cell-invasive activity through the induction of LPA receptor-1 in pancreatic cancer cells.
Fukushima K; Otagaki S; Takahashi K; Minami K; Ishimoto K; Fukushima N; Honoki K; Tsujiuchi T
J Recept Signal Transduct Res; 2018 Aug; 38(4):367-371. PubMed ID: 30396320
[TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidic acid-induced YAP/TAZ activation promotes developmental angiogenesis by repressing Notch ligand Dll4.
Yasuda D; Kobayashi D; Akahoshi N; Ohto-Nakanishi T; Yoshioka K; Takuwa Y; Mizuno S; Takahashi S; Ishii S
J Clin Invest; 2019 Jul; 129(10):4332-4349. PubMed ID: 31335323
[TBL] [Abstract][Full Text] [Related]
6. Diverse effects of LPA receptors on cell motile activities of cancer cells.
Tsujiuchi T; Hirane M; Dong Y; Fukushima N
J Recept Signal Transduct Res; 2014 Jun; 34(3):149-53. PubMed ID: 24460191
[TBL] [Abstract][Full Text] [Related]
7. Modulation of chemoresistance by lysophosphatidic acid (LPA) signaling through LPA
Minami K; Ueda N; Maeda H; Ishimoto K; Otagaki S; Tsujiuchi T
Biochem Biophys Res Commun; 2019 Sep; 517(2):359-363. PubMed ID: 31362892
[TBL] [Abstract][Full Text] [Related]
8. LPA
Minami K; Ueda N; Ishimoto K; Tsujiuchi T
Exp Cell Res; 2020 Mar; 388(1):111813. PubMed ID: 31904382
[TBL] [Abstract][Full Text] [Related]
9. Non-Edg family LPA receptors: the cutting edge of LPA research.
Yanagida K; Ishii S
J Biochem; 2011 Sep; 150(3):223-32. PubMed ID: 21746769
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of lysophosphatidic acid receptor-5 on cellular functions of sarcoma cells.
Araki M; Kitayoshi M; Dong Y; Hirane M; Ozaki S; Mori S; Fukushima N; Honoki K; Tsujiuchi T
Growth Factors; 2014 Jun; 32(3-4):117-22. PubMed ID: 24798396
[TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidic acid stimulates activation of focal adhesion kinase and paxillin and promotes cell motility, via LPA1-3, in human pancreatic cancer.
Liao Y; Mu G; Zhang L; Zhou W; Zhang J; Yu H
Dig Dis Sci; 2013 Dec; 58(12):3524-33. PubMed ID: 24061591
[TBL] [Abstract][Full Text] [Related]
12. Roles of lysophosphatidic acid (LPA) receptor-mediated signaling in cellular functions modulated by endothelial cells in pancreatic cancer cells under hypoxic conditions.
Takai M; Yashiro N; Hara K; Amano Y; Yamamoto M; Tsujiuchi T
Pathol Res Pract; 2024 Mar; 255():155192. PubMed ID: 38367602
[TBL] [Abstract][Full Text] [Related]
13. Opposite roles of LPA1 and LPA3 on cell motile and invasive activities of pancreatic cancer cells.
Kato K; Yoshikawa K; Tanabe E; Kitayoshi M; Fukui R; Fukushima N; Tsujiuchi T
Tumour Biol; 2012 Oct; 33(5):1739-44. PubMed ID: 22678979
[TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidic acid receptor 4 signaling potentially modulates malignant behavior in human head and neck squamous cell carcinoma cells.
Matayoshi S; Chiba S; Lin Y; Arakaki K; Matsumoto H; Nakanishi T; Suzuki M; Kato S
Int J Oncol; 2013 May; 42(5):1560-8. PubMed ID: 23467751
[TBL] [Abstract][Full Text] [Related]
15. Involvement of oncogenic K-ras on cell migration stimulated by lysophosphatidic acid receptor-2 in pancreatic cancer cells.
Yoshikawa K; Tanabe E; Shibata A; Inoue S; Kitayoshi M; Okimoto S; Fukushima N; Tsujiuchi T
Exp Cell Res; 2013 Feb; 319(3):105-12. PubMed ID: 23041208
[TBL] [Abstract][Full Text] [Related]
16. Effects of LPA
Takahashi K; Fukushima K; Otagaki S; Ishimoto K; Minami K; Fukushima N; Honoki K; Tsujiuchi T
J Recept Signal Transduct Res; 2018 Feb; 38(1):71-75. PubMed ID: 29369010
[TBL] [Abstract][Full Text] [Related]
17. Roles of endothelial cells in the regulation of cell motility via lysophosphatidic acid receptor-2 (LPA
Minami K; Ueda N; Ishimoto K; Kurisu R; Takamoto M; Ikeda H; Tsujiuchi T
Exp Mol Pathol; 2021 Feb; 118():104596. PubMed ID: 33347862
[TBL] [Abstract][Full Text] [Related]
18. Effects of LPA receptor-mediated signaling on the modulation of cellular functions of pancreatic cancer cells cultured in fibroblast supernatants under hypoxic conditions.
Takai M; Okuda A; Amano Y; Yashiro N; Hara K; Yamamoto M; Tsujiuchi T
J Bioenerg Biomembr; 2023 Jun; 55(3):169-177. PubMed ID: 37219648
[TBL] [Abstract][Full Text] [Related]
19. Involvement of LPA signaling via LPA receptor-2 in the promotion of malignant properties in osteosarcoma cells.
Takahashi K; Fukushima K; Tanaka K; Minami K; Ishimoto K; Otagaki S; Fukushima N; Honoki K; Tsujiuchi T
Exp Cell Res; 2018 Aug; 369(2):316-324. PubMed ID: 29859140
[TBL] [Abstract][Full Text] [Related]
20. Lysophosphatidic acid receptor-5 negatively regulates cell motile and invasive activities of human sarcoma cell lines.
Dong Y; Hirane M; Araki M; Fukushima N; Honoki K; Tsujiuchi T
Mol Cell Biochem; 2014 Aug; 393(1-2):17-22. PubMed ID: 24676544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
